Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Ion sequential therapy improves heart function after a heart attack.

Autophagy is important for human hair growth and health.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Ancestry affects skin healing, with non-Hispanic Black patients showing more healing-related fibroblasts than White patients.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Polygonum multiflorum, especially emodin, may help treat hair loss by targeting specific proteins, offering a new approach beyond traditional therapies.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Drug repositioning can save time and money but needs more support.

Tumor proteins can both promote and suppress cancer, depending on the situation.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Key proteins and potential drugs for treating alopecia areata were identified.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Different people show different symptoms for genetic diseases because of how sensitive their bodies are to small changes in important factors.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Bicalutamide may help treat female pattern hair loss.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.